Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Current Research Studies

A PHASE 3 STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF REVACCINATING PREGNANT PARTICIPANTS DURING SUBSEQUENT PREGNANCIES AND PERSISTENCE OF IMMUNITY OF A SINGLE DOSE OF A BIVALENT RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE

Marguerite_RSV_C3671059

  • Condition(s): Other
  • Phase: III
  • Clinicaltrials.gov ID: NCT06866405

What is the goal of the study?

This is a phase 3 study of revaccination in subsequent pregnancies with RSV Vaccine evaluating the duration of protection of a single dose.

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team: